Householders in the United States are preparing to upgrade their lighting with more energy efficient lamp technologies after the country's ban on 40W and 60W incandescent lamps came into force at the beginning of January. The phase out, ...
Tags: lighting, energy efficient lamp technology, incandescent lamps
Following U.S. phase out announcement of incandescent bulbs, northern neighbor Canada phase out of 75-100 watt incandescent bulbs will be effective as of Jan.1 , 2013, according to several Canadian media reports. Lower wattage bulbs of ...
According to the agency, its brief was to maintain a cohesive look and feel with Smithwick's masterbrand. The first ale to launch is 'Winter Spirit Ale' while a summer ale will launch this year. The Winter Ale is described as being a full ...
Tags: Packaging, Printing, Craft Beer Packaging
By Eleanor McDermid, Senior medwireNews Reporter Chronotherapy, involving total sleep deprivation and light therapy, brings about a rapid reduction in suicidality among patients with bipolar disorder experiencing a phase of major ...
Tags: chronotherapy, total sleep deprivation, light therapy, bipolar disorder
Two solid-state lighting (SSL) manufacturers are among the 12 businesses that will receive clean-energy tax credits ranging from $700,000 to $30m each (totaling more than $150m collectively), the US Department of Energy (DOE) has announced. ...
Tags: SSL LEDs, Electrical, Electronics
Feed-in tariffs (FIT) have been the preferred policy in many regions of the world to help support investors to rapidly increase installation of renewable energy installations projects and markets. Under most FITs, homeowners, businesses, ...
Tags: Feed-in Tariffs, PV Demand
Cerenis Therapeutics, the biopharmaceutical company, today announced that its Phase IIb CHI-SQUARE (Can HDL Infusions Significantly Quicken Atherosclerosis REgression) study did not reach its primary endpoint in post-Acute Coronary Syndrome ...
Tags: Cerenis Therapeutics, Phase IIb CHI-SQUARE, post-Acute Coronary Syndrome
Amgen (NASDAQ: AMGN) and UCB (Euronext Brussels:UCB) today announced results from a Phase 2 trial evaluating romosozumab (AMG 785/CDP7851) in postmenopausal women with low bone mineral density (BMD). Published in the New England Journal of ...
Tags: Amgen, UCB, Phase 2 trial evaluating romosozumab, postmenopausal women
India's Tata Steel has announced to commission an annual capacity of 6 million tons of steel project in Odisha, which will be put into production in March 2015. The company said the phase one project of the plant is about INR 25,164 ...
Tags: steel, metallurgy
About Aircraft batteries Parts and Its Product Range: Just as car batteries are used to start the engines, such are the purpose of aircraft batteries. However, there are many more differences than similarities, as an aircraft battery is ...
Tags: Manufacturing, Processing Machinery, Aircraft Batteries
The all-new user-friendly Multistatic 700 powder coating equipment helps you achieve highest productivity at the best powder coating quality. It features an integrated 100KV built-in electrostatic high voltage generator for enhanced ...
Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that the British Broadcasting Company (BBC) TV network ...
Can-Fite BioPharma Ltd. (TASE:CFBI), (NYSE MKT:CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its subsidiary OphthaliX Inc. (OTCBB:OPLI) ...
Tags: Can-Fite BioPharma, OphthaliX, placebo-controlled phase III study
Genzyme, a Sanofi company (EURONEXT:SAN and NYSE:SNY), announced today that it has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its supplemental Biologics License Application seeking approval of ...
Tags: Genzyme, Biologics License Application, Lemtrada, multiple sclerosis
Veloxis Pharmaceuticals A/S (OMX: VELO), today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the marketing and sale of Envarsus® (formerly ...
Tags: Veloxis Pharmaceuticals, New Drug Application, Envarsus®